Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

After years of preparation, Eli Lilly is on the brink of launching ... developing an add-on device for its existing pen range. Smart insulin pens are expected to drive the insulin pen market ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Novo Nordisk has made its smart insulin pens available in the UK ... The Danish pharma is trying to stay ahead of arch rivals Eli Lilly and Sanofi in an increasingly competitive insulin market ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

Which insulin brands are in shortage and why? Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter vials. The company said new regulations had ...

Right now, Eli Lilly dominates the weight loss industry thanks to its dual agonists Mounjaro and Zepbound. Viking ...

At the end of August, Eli Lilly announced it would sell single-use vials of Zepbound directly to patients at a significantly lower price than its injection pens. Affordability is Galindo's top ...

"I thought: No insulin? Death is imminent," Wright said. Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi ... 800 million insulin pens a year.

Eli Lilly and Company (NYSE: LLY) today announced detailed results from the QWINT-5 phase 3 trial evaluating once-weekly insulin efsitora alfa (efsitora) compared to once-daily insulin degludec in ...

We saw that happen with Eli Lilly (NYSE: LLY ... with sales rising 18% to nearly $880 million. Even Lilly's insulin product Humalog, which was first approved by the U.S. Food and Drug ...

Eli Lilly (NYSE: LLY ... Patients self-administer these drugs with an injection pen weekly, but Lilly recently launched single dose vials -- an option that's faster and cheaper for Lilly to ...